Name | Diprenorphine,17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α,α-dimethyl-6,14-ethenomorphinan-7-methanol |
---|---|
Synonyms |
DIPRENORPHINE
RX-5050M Diprenorphin DIPRENORPHINE POTENT OPIOID ANTAGON diprenorpine M-5050 |
Description | Diprenorphine is a non-selective opioid antagonist with Ki values of 0.017, 0.072 and 0.23 nM against κ-, μ- and δ-opioid receptors, respectively[1]. Diprenorphine can be used for central poststroke pain (CPSP) research[1]. |
---|---|
Related Catalog | |
Target |
Ki: 0.017 nM (κ-opioid receptor), 0.072 nM (μ-opioid receptor), 0.23 nM (δ-opioid receptor)[1] |
References |
Density | 1.33 g/cm3 |
---|---|
Molecular Formula | C26H35NO4 |
Molecular Weight | 425.56000 |
Exact Mass | 425.25700 |
PSA | 62.16000 |
LogP | 3.32550 |
Index of Refraction | 1.656 |
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | R20/21/22 |
Precursor 5 | |
---|---|
DownStream 0 |